Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

G-protein-coupled receptor heterodimerization modulates receptor function.

B A Jordan1, L A Devi

  • 1Department of Pharmacology, New York University School of Medicine, New York 10016, USA.

Nature
|June 29, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endothelin-converting enzyme 2 differentially regulates opioid receptor activity.

British journal of pharmacology·2014
Same author

Cannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosis.

Cell death & disease·2011
Same author

Animals lacking endothelin-converting enzyme-2 are deficient in learning and memory.

Genes, brain, and behavior·2011
Same author

Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence: THC effects.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2008
Same author

Morphine priming in rats with chronic inflammation reveals a dichotomy between antihyperalgesic and antinociceptive properties of deltorphin.

Neuroscience·2006
Same author

Functional interactions between mu opioid and alpha 2A-adrenergic receptors.

Molecular pharmacology·2003
Same journal

Incoming US science academy chief vows to 'double down' on research.

Nature·2026
Same journal

Author Correction: Synthesis of enantioenriched atropisomers by biocatalytic deracemization.

Nature·2026
Same journal

Electrodeposited self-assembled molecules for perovskite photovoltaics.

Nature·2026
Same journal

Neutrino's nursery found: the 'Shadow Blaster'.

Nature·2026
Same journal

Dementia risk in middle-aged people linked to a blood protein.

Nature·2026
Same journal

Daily briefing: What's really happening with trust in science.

Nature·2026
See all related articles

Two fully functional opioid receptors, kappa and delta, can form a heterodimer. This new kappa-delta receptor exhibits unique binding and signaling properties, offering novel insights into opioid receptor modulation.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Molecular Biology

Background:

  • The opioid system regulates vital physiological processes like pain, stress, and immune responses.
  • Three main opioid receptor types (delta, kappa, mu) have been identified, mediating diverse effects.
  • G-protein-coupled receptors (GPCRs), including opioid receptors, are known to form homodimers and functional heterodimers from non-functional receptors.

Purpose of the Study:

  • To investigate the potential heterodimerization of two fully functional opioid receptors.
  • To characterize the functional and pharmacological properties of such a heterodimer.
  • To explore novel mechanisms of opioid receptor modulation.

Main Methods:

  • Biochemical assays to provide evidence of heterodimerization.

Related Experiment Videos

  • Pharmacological studies to assess ligand binding and functional activity.
  • Analysis of signal transduction pathways potentiated by the heterodimer.

    • Main Results:

    • Biochemical and pharmacological evidence confirms the heterodimerization of functional kappa and delta opioid receptors.
    • The resulting kappa-delta heterodimer displays distinct ligand binding and functional characteristics compared to individual receptors.
    • This heterodimer exhibits synergistic agonist binding and potentiated signal transduction.

    Conclusions:

    • Heterodimerization between two fully functional opioid receptors (kappa and delta) is demonstrated.
    • This novel kappa-delta heterodimer represents a new functional entity with unique pharmacological properties.
    • Opioid receptor heterodimerization offers a previously unrecognized mechanism for modulating opioid system function.